This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Holy Name Medical Center Earns "Top Performer On Key Quality Measures™" Recognition From The Joint Commission

TEANECK, N.J., Oct. 30, 2013 /PRNewswire/ -- Holy Name Medical Center (HNMC) was named one of the nation's Top Performers on Key Quality Measures for 2012 by The Joint Commission, the leading accreditor of healthcare organizations in America. Holy Name was cited by the Joint Commission for exemplary performance in using evidence-based clinical processes that are shown to improve care for certain conditions.   Holy Name was recognized for its achievement on the following measure sets: Heart Attack, Heart Failure, Pneumonia and Surgical Care.

HNMC is one of 1099 hospitals in the United States earning the distinction of Top Performer on Key Quality Measures for attaining and sustaining excellence in accountability measure performance.   The ratings are based on an aggregation of accountability measure data reported to The Joint Commission during the 2012 calendar year.  This is the third year in a row that HNMC is being recognized as a Top Performer.

To be recognized as a top performer, a hospital must meet or exceed 95 percent performance thresholds for its composite performance on all reported accountability measures, as well as its performance on every single accountability measure for which it reports data to The Joint Commission.

Examples of core accountability measures for surgical care include but are not limited to "preventive antibiotic started 1 hour prior to incision," and "treatment preventing blood clots received."  Core accountability measures for pneumonia include but are not limited to "antibiotic timing within six hours of admission" and "pneumonia and influenza vaccination." Examples of heart attack measures are "aspirin at discharge" and "smoking cessation advice." "Smoking cessation advice" is also a core measure for heart failure, as are measures that include written discharge instructions or other educational material that address "weight monitoring" and "diet/fluid intake" and "what to do if heart failure symptoms worsen after discharge."

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,076.27 +64.33 0.36%
S&P 500 2,114.07 +4.47 0.21%
NASDAQ 5,099.2310 +22.7070 0.45%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs